JPH10510276A - アルツハイマー病の処置における乳香の使用 - Google Patents
アルツハイマー病の処置における乳香の使用Info
- Publication number
- JPH10510276A JPH10510276A JP8518143A JP51814396A JPH10510276A JP H10510276 A JPH10510276 A JP H10510276A JP 8518143 A JP8518143 A JP 8518143A JP 51814396 A JP51814396 A JP 51814396A JP H10510276 A JPH10510276 A JP H10510276A
- Authority
- JP
- Japan
- Prior art keywords
- frankincense
- physiologically acceptable
- derivatives
- salts
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/324—Boswellia, e.g. frankincense
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.乳香、乳香の抽出物、乳香に含まれる物質、それらの生理学的に許容される 塩、それらの誘導体およびその生理学的に許容される塩の、純粋なボスウェリン 酸の、生理学的に許容される塩の、誘導体の、誘導体の塩の、アルツハイマー病 の予防および治療的処置のための薬剤を製造するための使用。 2.純粋なボスウェリン酸、生理学的に許容される塩、誘導体、誘導体の塩、ボ スウェリン酸を含有する乳香の抽出物が薬剤の製造のために用いられることを特 徴とする、請求項1による使用。 3.ボスウェリア鋸歯状葉の樹脂の抽出物が薬剤の製造のために用いられること を特徴とする、請求項1又は2の1つによる使用。 4.該使用が腹膜組織内、口腔内、舌下、直腸内、筋肉内、局所、皮下、関節内 または静脈内投与のための薬剤の製造のために有効であることを特徴とする、請 求項1〜3の1つによる使用。 5.該使用が錠剤、糖衣剤、カプセル剤、注射剤溶液、溶液剤、乳剤、軟膏剤、 クリーム剤、吸入剤、エアゾール剤または座剤の形態にある薬剤の製造のために 有効であることを特徴とする、請求項1〜3の1つによる使用。 6.乳香、乳香の抽出物、乳香に含まれる物質、それらの生理学的に許容される 塩、それらの誘導体およびその生理学的に許容される塩の、純粋なボスウェリン 酸の、生理学的に許容される塩の、誘導体の、誘導体の塩の、アルツハイマー病 の予防および治療のための使用。 7.純粋なボスウェリン酸、生理学的に許容される塩、誘導体、誘導体の塩、ボ スウェリン酸を含有する乳香の抽出物が上記処置のために用いられることを特徴 とする、請求項6による使用。 8.ボスウェリア鋸歯状葉の樹脂の抽出物が上記処置のために用いられることを 特徴とする、請求項6又は7の1つによる使用。 9.該使用が錠剤、糖衣剤、カプセル剤、注射剤溶液、溶液剤、乳剤、軟膏剤、 クリーム剤、吸入剤、エアゾール剤または座剤の形態において有効であることを 特徴とする、請求項6〜8の1つによる使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4444288.2 | 1994-12-13 | ||
DE4444288A DE4444288A1 (de) | 1994-12-13 | 1994-12-13 | Verwendung von Weihrauch zur Behandlung der Alzheimer-Krankheit |
PCT/EP1995/004586 WO1996018407A1 (de) | 1994-12-13 | 1995-11-21 | Verwendung von weihrauch zur behandlung der alzheimer-krankheit |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH10510276A true JPH10510276A (ja) | 1998-10-06 |
Family
ID=6535638
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP8518143A Ceased JPH10510276A (ja) | 1994-12-13 | 1995-11-21 | アルツハイマー病の処置における乳香の使用 |
Country Status (15)
Country | Link |
---|---|
US (1) | US5720975A (ja) |
EP (1) | EP0796103B1 (ja) |
JP (1) | JPH10510276A (ja) |
CN (1) | CN1092973C (ja) |
AT (1) | ATE198550T1 (ja) |
CA (1) | CA2207437A1 (ja) |
CZ (1) | CZ288071B6 (ja) |
DE (2) | DE4444288A1 (ja) |
DK (1) | DK0796103T3 (ja) |
ES (1) | ES2153906T3 (ja) |
GR (1) | GR3035402T3 (ja) |
PL (1) | PL320687A1 (ja) |
PT (1) | PT796103E (ja) |
RU (1) | RU2184562C2 (ja) |
WO (1) | WO1996018407A1 (ja) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19531067A1 (de) * | 1995-08-23 | 1997-02-27 | Hermann P T Prof Dr Med Ammon | Verwendung von Boswelliasäure und ihren Derivaten zur Hemmung der normalen und gesteigerten Leukozytenelastase- oder Plasminaktivität |
US6193993B1 (en) * | 1998-03-03 | 2001-02-27 | Eisai Co., Ltd. | Suppository containing an antidementia medicament |
AU2001287743A1 (en) * | 2000-09-20 | 2002-04-02 | R.P. Scherer Gmbh And Co. Kg | Oral dosage forms of boswellia extracts |
WO2002066491A1 (en) * | 2001-02-15 | 2002-08-29 | Sabinsa Corporation | Water soluble boswellic acids, their preparation and use for treating imflammatory conditions |
GB0201508D0 (en) * | 2002-01-23 | 2002-03-13 | Novartis Ag | Organic compounds |
CN1304007C (zh) * | 2002-02-04 | 2007-03-14 | 中国医学科学院药物研究所 | 乙酰乳香酸在制备肿瘤转移抑制剂中的应用 |
DE10331750A1 (de) * | 2003-07-14 | 2005-02-10 | Keyneurotek Ag | Verwendung der Hydrierungsprodukte von Weihrauch (Olibanum) zur Prophylaxe und/oder Behandlung von zerebraler Ischämie, Schädel/Hirntrauma und/oder Alzheimer-Krankheit |
US7645461B2 (en) * | 2003-03-18 | 2010-01-12 | Key Neurotek AG | Method of treating cerebral ischemia with hydrogenation products of frankincense extracts |
CN100569245C (zh) * | 2005-06-02 | 2009-12-16 | 成都中医药大学 | 乳香在制备治疗痛风的药物中的用途 |
BRPI0913499B1 (pt) | 2008-09-15 | 2020-03-17 | Laila Nutraceuticals | Composições anti-inflamatórias sinergísticas compreendendo extratos de boswellia serrata |
WO2010105821A1 (de) | 2009-03-17 | 2010-09-23 | Herta Ertelt | Verfahren zur extraktion von pflanzlichen harzen sowie dadurch gewonnene extraktionsprodukte und deren verwendung |
US10940175B2 (en) | 2009-07-18 | 2021-03-09 | Compton Developments Ltd. | Inhibitor of inflammatory conditions |
EP3868391B1 (en) * | 2009-07-18 | 2024-05-22 | Compton Developments Limited | Therapeutic uses of an organic solvent extract of boswellia frereana oleoresin |
AU2011228689A1 (en) * | 2010-03-15 | 2012-09-27 | Laila Nutraceuticals | Boswellia oil, its fractions and compositions for enhancing brain function |
US8828377B2 (en) | 2010-03-15 | 2014-09-09 | Laila Nutraceuticals | Boswellia oil, its fractions and compositions for enhancing brain function |
DK2613777T3 (da) | 2010-09-07 | 2019-07-01 | Regenera Pharma Ltd | Sammensætninger omfattende sure ekstrakter af mastiks-gummi |
US11123364B2 (en) | 2011-06-21 | 2021-09-21 | Bvw Holding Ag | Medical device comprising boswellic acid |
ITPD20120343A1 (it) * | 2012-11-13 | 2014-05-14 | Matteo Bevilacqua | Composto in particolare per la cura della depressione e dell'ansia |
CN103393740B (zh) * | 2013-07-31 | 2015-10-14 | 中国人民解放军第四军医大学 | 乳香提取物在防治心脑血管或肝肾损伤中应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5064823A (en) * | 1988-08-24 | 1991-11-12 | Research Triangle Institute | Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers |
CA1330944C (en) * | 1988-08-24 | 1994-07-26 | De-Hua Li | Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers |
CN1053363A (zh) * | 1990-09-11 | 1991-07-31 | 李竞 | 能预防和缓解痛经的香水 |
US5280119A (en) * | 1991-11-01 | 1994-01-18 | Boron Biologicals, Inc. | Heterocyclic amine-boranes, and method of inhibiting DNA topoisomerase activity and/or combatting inflammation, hyperlipidemia, and/or neoplasia using amine-borane compounds |
DE4201903B4 (de) * | 1992-01-24 | 2004-04-15 | Hermann P.T. Prof. Dr.Med. Ammon | Pharmazeutische Verwendung von Boswelliasäuren |
CN1033331C (zh) * | 1992-11-13 | 1996-11-20 | 中国科学院长春应用化学研究所 | 聚芳醚砜/液晶高聚物分子复合材料及制备方法 |
CN1046088C (zh) * | 1992-12-19 | 1999-11-03 | 管遵信 | 一种中药美容液及其生产方法 |
CN1030373C (zh) * | 1993-03-27 | 1995-11-29 | 张会来 | 腰痹灵 |
US5494668A (en) * | 1994-07-11 | 1996-02-27 | Patwardhan; Bhushan | Method of treating musculoskeletal disease and a novel composition therefor |
-
1994
- 1994-12-13 DE DE4444288A patent/DE4444288A1/de not_active Withdrawn
-
1995
- 1995-11-21 EP EP95940992A patent/EP0796103B1/de not_active Expired - Lifetime
- 1995-11-21 PL PL95320687A patent/PL320687A1/xx unknown
- 1995-11-21 PT PT95940992T patent/PT796103E/pt unknown
- 1995-11-21 JP JP8518143A patent/JPH10510276A/ja not_active Ceased
- 1995-11-21 CN CN95197353A patent/CN1092973C/zh not_active Expired - Fee Related
- 1995-11-21 DK DK95940992T patent/DK0796103T3/da active
- 1995-11-21 DE DE59508961T patent/DE59508961D1/de not_active Expired - Fee Related
- 1995-11-21 AT AT95940992T patent/ATE198550T1/de not_active IP Right Cessation
- 1995-11-21 RU RU97112084/14A patent/RU2184562C2/ru not_active IP Right Cessation
- 1995-11-21 CA CA002207437A patent/CA2207437A1/en not_active Abandoned
- 1995-11-21 WO PCT/EP1995/004586 patent/WO1996018407A1/de active IP Right Grant
- 1995-11-21 ES ES95940992T patent/ES2153906T3/es not_active Expired - Lifetime
- 1995-11-21 CZ CZ19971773A patent/CZ288071B6/cs not_active IP Right Cessation
-
1997
- 1997-02-05 US US08/796,857 patent/US5720975A/en not_active Expired - Fee Related
-
2001
- 2001-02-12 GR GR20010400230T patent/GR3035402T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
WO1996018407A1 (de) | 1996-06-20 |
EP0796103A1 (de) | 1997-09-24 |
EP0796103B1 (de) | 2001-01-10 |
CZ288071B6 (cs) | 2001-04-11 |
PL320687A1 (en) | 1997-10-27 |
DE59508961D1 (de) | 2001-02-15 |
GR3035402T3 (en) | 2001-05-31 |
ATE198550T1 (de) | 2001-01-15 |
CZ177397A3 (en) | 1997-11-12 |
US5720975A (en) | 1998-02-24 |
DE4444288A1 (de) | 1996-06-20 |
PT796103E (pt) | 2001-04-30 |
DK0796103T3 (da) | 2001-03-05 |
RU2184562C2 (ru) | 2002-07-10 |
CN1173134A (zh) | 1998-02-11 |
ES2153906T3 (es) | 2001-03-16 |
CA2207437A1 (en) | 1996-06-20 |
CN1092973C (zh) | 2002-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH10510276A (ja) | アルツハイマー病の処置における乳香の使用 | |
CA3146050A1 (en) | Metered dosing compositions and methods of use of psychedelic compounds | |
CA2914089C (en) | Nicotine-containing liquid formulations and uses thereof | |
NO328797B1 (no) | Anvendelse av essensielle fettsyrer inneholdende en blanding av eikosapentaensyreetylester (EPA) og docosaheksaensyreetylester (DHA) for fremstilling av et medikament nyttig ved forebyggelse av dodsfall hos en pasient som har hatt et hjerteinfarkt. | |
WO1995017889A1 (fr) | Composition therapeutique utile pour traiter l'hyperparathyroidie d'un patient en dialyse artificielle | |
US4690927A (en) | Pharmaceutical compositions with analgesic properties and the preparation and use thereof | |
WO2005084392A2 (en) | 4-methylpyrazole formulations for inhibiting ethanol intolerance | |
GB2368012A (en) | Preparation for the relief of inflammatory disease | |
KR20000038194A (ko) | 이소발레린산 유도체 cns 억제제를 이용한 경련, 경직의 처치 | |
WO2012090194A2 (en) | Compositions and methods for treating a skin disorder | |
UA70310C2 (uk) | Спосіб лікування ожиріння та комбінований препарат, який містить сибутрамін та орлістат (варіанти) | |
US6022889A (en) | Pharmaceutical preparations containing bilobalide for the treatment of tension and anxiety | |
KR101401628B1 (ko) | 간기능 개선용 정제 및 그 제조 방법 | |
WO1996030016A3 (en) | Low dose ridogrel formulations and their use for the treatment of inflammatory bowel diseases | |
WO2022251116A1 (en) | Modified herbal compositions for neuromodulation | |
CA2916077C (en) | Nicotine-containing solid oral formulations and uses thereof | |
CN100509017C (zh) | 治疗胆道感染的药物及其制备方法 | |
JP6864964B2 (ja) | 経口睡眠改善剤 | |
WO2016041438A1 (zh) | 一种柚皮苷与盐酸非索非那丁药物组合物及其制剂 | |
CN112691102A (zh) | 黄芩素在防治帕金森病/帕金森综合征抑郁症状中的应用 | |
KR0155976B1 (ko) | 항스트레스 의약조성물 | |
KR20210023872A (ko) | Rls 치료를 위한 님 | |
CN114569589A (zh) | 一种天然小分子及其在药物制备中的用途 | |
CN110893183A (zh) | 银杏萜内酯在制备预防、缓解或治疗肌萎缩侧索硬化药物中的应用 | |
CN113842417A (zh) | 一种舒缓助眠草本配方及制作方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060314 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20060601 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20060714 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20061023 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20061205 |